Overview
The Metabolic & Biomedicine Lab (MBL) stands at the intersection of environmental health and metabolic medicine. We investigate how modern environmental pollutants disrupt fundamental metabolic pathways — working across molecular signaling, cellular biology, and whole-organism models — and how nature-derived compounds can restore balance. Our work integrates molecular biology, environmental toxicology, and natural product science to uncover mechanisms and develop therapeutic strategies against metabolic disease.
Environmental Pollutants & Metabolic Disruption
We investigate how environmental pollutants enter biological systems and interfere with metabolic homeostasis — disrupting hormonal signaling, inflammatory balance, glucose & fat metabolism and energy regulation at the molecular and systemic level.
Our research covers:
Micro- and Nanoplastics (MNPs) — disruption of insulin signaling (IRS-1/AKT/GLUT4), lipid metabolism, and glucose homeostasis; cellular internalization, oxidative stress induction, and gut-metabolic axis interference
Particulate Matter (PM₁₀) — inflammatory activation via NF-κB and NLRP3 inflammasome, mitochondrial stress, and systemic metabolic dysregulation linked to obesity and T2D risk
Persistent Organic Pollutants (POPs) — obesogenic/diabetogenic mechanisms including altered lipid storage and pancreatic β-cell toxicity
Endocrine-Disrupting Chemicals (EDCs) — interference with nuclear receptor signaling (PPARγ) driving adipogenesis, thyroid dysfunction, and insulin resistance
Lifestyle, Diet & Metabolic Disease: The Metabolic Cost of Modern Life
Unhealthy dietary patterns are among the leading drivers of metabolic disease. We model and investigate how diet-induced metabolic stress mirrors and interacts with pollutant-induced dysfunction — spanning cellular, and systemic levels.
Our research covers:
High-fat and high-glucose diets (HFD/HG) — obesity, insulin resistance, dyslipidemia, and the progression from simple steatosis to NAFLD, MASH (metabolic dysfunction-associated steatohepatitis), and MASL (metabolic dysfunction-associated steatotic liver disease)
Diet-induced liver disease — mechanisms driving hepatic lipid accumulation, inflammation, fibrosis, and the NAFLD→MASH continuum
Intermittent fasting and caloric restriction — metabolic reprogramming, energy sensing (AMPK, mTOR, SIRT1), and protective mechanisms against obesity, T2D, and fatty liver disease
Diet–pollutant interactions — how dietary metabolic stress amplifies or modifies toxicant-induced metabolic dysfunction
Insulin Resistance & Metabolic Signaling
At the core of our research is understanding the molecular basis of insulin resistance — across both pollutant-exposed and diet-induced models — and how disrupted signaling cascades drive systemic metabolic disease.
Our research covers:
Insulin signaling pathway disruption
Inflammatory crosstalk
Lipotoxicity and ectopic fat accumulation
Mitochondrial dysfunction
Adipokine and hepatokine dysregulation
Crosstalk between pollutant- and diet-induced models
Herbal & Natural Interventions (Core Focus)
A core mission of our lab is identifying and validating evidence-based natural compounds that counteract pollutant-induced metabolic dysfunction:
Screening herbal extracts for anti-diabetic and anti-obesity activity
Mechanistic evaluation of bioactive phytochemicals on metabolic pathways
Development of natural therapeutic strategies targeting insulin resistance and inflammation